-
-
(S)-(+)-DBD-APy [=(S)-(+)-4-(N，N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2，1，3-benzoxadiazole],98%, 10mg
-
(R)-(-)-DBD-APy [=(R)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2，1，3-benzoxadiazole],98%, 10mg
-
(R)-(-)-DBD-APy [=(R)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2，1，3-benzoxadiazole],98%, 50mg
-
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2，1，3-benzoxadiazole],98%, 10mg
-
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2，1，3-benzoxadiazole],98%, 50mg
-
DBD-COCl [=4-(N，N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2，1，3-benzoxadiazole],93%, 10mg
-
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2，1，3-benzoxadiazole],90%, 10mg
-
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2，1，3-benzoxadiazole],90%, 50mg
-
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N，N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2，1，3-benzoxadiazole],90%, 100mg
-
(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N，N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2，1，3-benzoxadiazole],≥98%, 100mg
-
Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2，5，7，8-tetramethylchroman-2-carboxylate,, 5mg
стр.: